Skip to main content
logo
Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
2.440
+0.150 (6.55%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Radiopharm Theranostics Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
3134122426-
Market Cap Growth
-16.62%192.24%-50.78%-10.18%--
Enterprise Value
591084-
Last Close Price
2.444.64----

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
2.864.168.935.74--
PB Ratio
0.931.210.640.780.61-
P/TBV Ratio
6.96---5.56-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
0.461.158.022.04--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
------0.47
Net Debt / Equity Ratio
-0.69-0.68-0.68-0.26-0.43-0.26
Net Debt / EBITDA Ratio
0.880.900.580.461.59-
Net Debt / FCF Ratio
0.930.800.810.502.72-0.40
Asset Turnover
0.180.160.030.08--
Quick Ratio
3.002.651.111.223.430.21
Current Ratio
3.012.671.301.233.460.21
Return on Equity (ROE)
-92.10%-109.20%-131.49%-63.78%-96.82%-
Return on Assets (ROA)
-28.33%-27.70%-30.04%-22.57%-29.86%-
Return on Capital Employed (ROCE)
-54.80%-49.10%-64.90%-46.30%-26.40%932.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-99.94%-73.69%-274.09%-97.15%-79.40%-
FCF Yield
-85.54%-70.43%-131.34%-65.25%-25.86%-
Buyback Yield / Dilution
-114.63%-438.49%-26.36%-68.74%--
SEC Filings: 10-K · 10-Q